RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

Early surface reconnaissance and drilling progress sharpen silver focus HIGHLIGHTS Current ~2,500m reverse circulation (RC) ...

A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer—and offers a potential pathway ...

This study provides useful information on the impact of Lamin A/C knockdown on gene expression using RNA-Seq analysis. In addition, the impact of Lamin A/C knockdown on telomere dynamics is explored ...

The Molecular Biology Enzymes, Kits & Reagents Market plays a pivotal role in advancing scientific research and biotechnology development globally. These products form the backbone of molecular ...

Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

Rocket Pharmaceuticals halted its Danon disease gene therapy trial after a patient death, with the FDA placing the study on ...

From $1.64 billion in 2024 ... Market Report: What Key Factors Are Driving The Growth Of The Familial Mediterranean Fever Pharmaceuticals Market? Moving forward, gene therapy is expected to ...